4//SEC Filing
Burkly Linda 4
Accession 0001650664-25-000163
CIK 0001650664other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:39 PM ET
Size
5.0 KB
Accession
0001650664-25-000163
Insider Transaction Report
Form 4
Burkly Linda
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Common Stock
2025-12-03$2.15/sh−713$1,535→ 68,777 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001985604
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 4:39 PM ET
- Size
- 5.0 KB